REPLIGEN CORP (RGEN) Operating income 2016–2025
REPLIGEN CORP (RGEN) annual operating income history from SEC filings — each fiscal year as reported.
$55.2MFY2025 · since FY2016: $16.0M → $55.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55.2M | +257.1% |
| FY2024 | -$35.1M | -173.6% |
| FY2023 | $47.7M | -78.8% |
| FY2022 | $224.7M | +34.3% |
| FY2021 | $167.2M | +139.5% |
| FY2020 | $69.8M | +93.5% |
| FY2019 | $36.1M | +38.8% |
| FY2018 | $26.0M | +85.6% |
| FY2017 | $14.0M | -12.3% |
| FY2016 | $16.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice